Evaluation of the safety and efficacy of ultrasound-guided percutaneous radiofrequency ablation for hepatocellular carcinoma and liver metastases adjacent to the gallbladder

References

• Mansur A, Garg T, Shrigiriwar A, et al. Image-guided percutaneous ablation for primary and metastatic tumors. Diagnostics. 2022;12(6):1300.
   Web of Science ®Google Scholar
• Deng Q, He M, Fu C, et al. Radiofrequency ablation in the treatment of hepatocellular carcinoma. Int J Hyperth. 2022;39(1):1052–1063.
   PubMed Web of Science ®Google Scholar
• Yang G, Wang G, Sun J, et al. The prognosis of radiofrequency ablation versus hepatic resection for patients with colorectal liver metastases: a systematic review and meta-analysis based on 22 studies. Int J Surg. 2021;87:105896.
   PubMed Web of Science ®Google Scholar
• Wang LJ, Zhang ZY, Yan XL, et al. Radiofrequency ablation versus resection for technically resectable colorectal liver metastasis: a propensity score analysis. World J Surg Onc. 2018;16(1):207.
   PubMed Web of Science ®Google Scholar
• Vietti Violi N, Duran R, Demartines N, et al. Local recurrence rate in patients with colorectal cancer liver metastasis after wedge resection or percutaneous radiofrequency ablation. Int J Hyperthermia. 2018;34(7):1020–1028.
   PubMed Web of Science ®Google Scholar
• Toshimori J, Nouso K, Nakamura S, et al. Local recurrence and complications after percutaneous radiofrequency ablation of hepatocellular carcinoma: a retrospective cohort study focused on tumor location. Acta Med Okayama. 2015;69(4):219–226.
   PubMed Web of Science ®Google Scholar
• Levit E, Bruners P, Günther RW, et al. Bile aspiration and hydrodissection to prevent complications in hepatic RFA close to the gallbladder. Acta Radiol. 2012;53(9):1045–1048.
   PubMed Web of Science ®Google Scholar
• Azevedo A, Falsarella P, Rocha R, et al. Percutaneous cholecystostomy and hydrodissection in radiofrequency ablation of liver subcapsular leiomyosarcoma metastasis adjacent to the gallbladder: protective effect. J Radiol Case Rep. 2016;10(10):24–32.
   PubMedGoogle Scholar
• Fan J, He S, Zheng Y. Analyses of clinical efficacy of ultrasound-guided radiofrequency ablation in liver cancer adjacent to the gallbladder and its prognosis. J Buon. 2019;24(6):2411–2417.
   PubMed Web of Science ®Google Scholar
• Garnon J, Koch G, Caudrelier J, et al. Hydrodissection of the gallbladder bed: a technique for ablations located close to the gallbladder. Cardiovasc Intervent Radiol. 2019;42(7):1029–1035.
   PubMed Web of Science ®Google Scholar
• Benson AB, D’Angelica MI, Abbott DE, et al. Hepatobiliary cancers, version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Network. 2021;19(5):541–565.
   PubMed Web of Science ®Google Scholar
• Heimbach JK, Kulik LM, Finn RS, et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology. 2018;67(1):358–380.
   PubMed Web of Science ®Google Scholar
• Van Cutsem E, Cervantes A, Adam R, et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol. 2016;27(8):1386–1422.
   PubMed Web of Science ®Google Scholar
• Yoshino T, Arnold D, Taniguchi H, et al. Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO-ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS. Ann Oncol. 2018;29(1):44–70.
   PubMed Web of Science ®Google Scholar
• Benson AB, Venook AP, Al-Hawary MM, et al. Colon cancer, version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Comp Cancer Network. 2021;19(3):329–359.
   PubMed Web of Science ®Google Scholar
• Kew MC. Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma. Pathol Biol. 2010;58(4):273–277.
   PubMedGoogle Scholar
• Kanda T, Goto T, Hirotsu Y, et al. Molecular mechanisms driving progression of liver cirrhosis towards hepatocellular carcinoma in chronic hepatitis B and C infections: a review. Int J Mol Sci. 2019;20(6):1358.
   PubMed Web of Science ®Google Scholar
• Konyn P, Ahmed A, Kim D. Current epidemiology in hepatocellular carcinoma. Expert Rev Gastroenterol Hepatol. 2021;15(11):1295–1307.
   PubMed Web of Science ®Google Scholar
• Wang H, Lee JC, Cao K, et al. What is the difference in ablation zone of multi-bipolar radiofrequency ablation between liver cirrhosis and normal liver background? – A prospective clinical study. Int J Hyperther. 2020;37(1):1248–1259.
   PubMed Web of Science ®Google Scholar
• Omata M, Cheng AL, Kokudo N, et al. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatol Int. 2017;11(4):317–370.
   PubMed Web of Science ®Google Scholar
• Wang X, Sofocleous CT, Erinjeri JP, et al. Margin size is an independent predictor of local tumor progression after ablation of Colon cancer liver metastases. Cardiovasc Intervent Radiol. 2013;36(1):166–175.
   PubMed Web of Science ®Google Scholar
• Sotirchos VS, Petrovic LM, Gönen M, et al. Colorectal cancer liver metastases: biopsy of the ablation zone and margins can be used to predict oncologic outcome. Radiology. 2016;280(3):949–959.
   PubMed Web of Science ®Google Scholar
• Shady W, Petre EN, Do KG, et al. Percutaneous microwave versus radiofrequency ablation of colorectal liver metastases: ablation with clear margins (A0) provides the best local tumor control. J Vasc Interv Radiol. 2018;29(2):268–275.e261.
   PubMed Web of Science ®Google Scholar
• Yan K, Yang W, Chen MH, et al. Clinical application of hepatic wedge ablation for treating liver malignancies of the inferior margin: a new ablation technique. Int J Hyperth. 2017;33(2):203–211.
   PubMed Web of Science ®Google Scholar
• Chen MH, Wei Y, Yan K, et al. Treatment strategy to optimize radiofrequency ablation for liver malignancies. J Vasc Interv Radiol. 2006;17(4):671–683.
   PubMed Web of Science ®Google Scholar
• Chopra S, Dodd GD, 3rd, Chanin MP, et al. Radiofrequency ablation of hepatic tumors adjacent to the gallbladder: feasibility and safety. AJR Am J Roentgenol. 2003;180(3):697–701.
   PubMed Web of Science ®Google Scholar
• Ahmed M, Solbiati L, Brace CL, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria–a 10-year update. Radiology. 2014;273(1):241–260.
   PubMed Web of Science ®Google Scholar
• Lee J, Rhim H, Jeon YH, et al. Radiofrequency ablation of liver adjacent to body of gallbladder: histopathologic changes of gallbladder wall in a pig model. AJR Am J Roentgenol. 2008;190(2):418–425.
   PubMed Web of Science ®Google Scholar
• Livraghi T, Goldberg SN, Lazzaroni S, et al. Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology. 1999;210(3):655–661.
   PubMed Web of Science ®Google Scholar
• Liu Z, Ahmed M, Weinstein Y, et al. Characterization of the RF ablation-induced ‘oven effect’: the importance of background tissue thermal conductivity on tissue heating. Int J Hyperther. 2006;22(4):327–342.
   PubMed Web of Science ®Google Scholar
• Hayashi H, Nabeshima K, Hamasaki M, et al. Presence of microsatellite lesions with colorectal liver metastases correlate with intrahepatic recurrence after surgical resection. Oncol Rep. 2009;21(3):601–607.
   PubMed Web of Science ®Google Scholar
• Tewari SO, Petre EN, Osborne J, et al. Cholecystokinin-assisted hydrodissection of the gallbladder fossa during FDG PET/CT-guided liver ablation. Cardiovasc Intervent Radiol. 2013;36(6):1704–1706.
   PubMed Web of Science ®Google Scholar
• Petit A, Hocquelet A, N'kontchou G, et al. No-Touch multi-bipolar radiofrequency ablation for the treatment of subcapsular hepatocellular carcinoma ≤5 cm not puncturable via the non-tumorous liver parenchyma. Cardiovasc Intervent Radiol. 2020;43(2):273–283.
   PubMed Web of Science ®Google Scholar
• Liu C, He J, Li T, et al. Evaluation of the efficacy and postoperative outcomes of hydrodissection-assisted microwave ablation for subcapsular hepatocellular carcinoma and colorectal liver metastases. Abdom Radiol. 2021;46(5):2161–2172.
   PubMed Web of Science ®Google Scholar
• Lee DH, Lee JM, Lee JY, et al. Radiofrequency ablation of hepatocellular carcinoma as first-line treatment: long-term results and prognostic factors in 162 patients with cirrhosis. Radiology. 2014;270(3):900–909.
   PubMed Web of Science ®Google Scholar
• Yang W, Yan K, Goldberg SN, et al. Ten-year survival of hepatocellular carcinoma patients undergoing radiofrequency ablation as a first-line treatment. World J Gastroenterol. 2016;22(10):2993–3005.
   PubMed Web of Science ®Google Scholar
• Kim GA, Shim JH, Kim MJ, et al. Radiofrequency ablation as an alternative to hepatic resection for single small hepatocellular carcinomas. Br J Surg. 2015;103(1):126–135.
   PubMed Web of Science ®Google Scholar
• Orlacchio A, Chegai F, Del Giudice C, et al. Radiofrequency thermoablation of HCC larger than 3 cm and less than 5 cm proximal to the gallbladder without gallbladder isolation: a single center experience. Biomed Res Int. 2014;2014:896527.
   PubMed Web of Science ®Google Scholar
• Bai XM, Cui M, Yang W, et al. The 10-year survival analysis of radiofrequency ablation for solitary hepatocellular carcinoma 5 cm or smaller: primary versus recurrent HCC. Radiology. 2021;300(2):458–469.
   PubMed Web of Science ®Google Scholar
• Chen MH, Yang W, Yan K, et al. Large liver tumors: protocol for radiofrequency ablation and its clinical application in 110 patients–mathematic model, overlapping mode, and electrode placement process. Radiology. 2004;232(1):260–271.
   PubMed Web of Science ®Google Scholar
• Pan C, Wu P, Yu J, et al. CT-guided radiofrequency ablation prolonged metastatic survival in patients with liver metastases from nasopharyngeal carcinoma. Int J Hypertherm. 2011;27(6):549–554.
   PubMed Web of Science ®Google Scholar
• Chen YP, Chan ATC, Le QT, et al. Nasopharyngeal carcinoma. Lancet. 2019;394(10192):64–80.
   PubMed Web of Science ®Google Scholar
• Jin Y, Cai YC, Cao Y, et al. Radiofrequency ablation combined with systemic chemotherapy in nasopharyngeal carcinoma liver metastases improves response to treatment and survival outcomes. J. Surg. Oncol. 2012;106(3):322–326.
   PubMed Web of Science ®Google Scholar
• Hoshino S, Furukawa M, Aragane K, et al. Successful multimodal treatment in a patient with thymoma accompanied by hepatic metastasis. J Thorac Oncol. 2008;3(1):98–100.
   PubMed Web of Science ®Google Scholar